Pharmacogenomics: current status and future perspectives

M Pirmohamed - Nature Reviews Genetics, 2023 - nature.com
Inter-individual variability in drug response, be it efficacy or safety, is common and likely to
become an increasing problem globally given the growing elderly population requiring …

The genetics of bipolar disorder

FJA Gordovez, FJ McMahon - Molecular psychiatry, 2020 - nature.com
Bipolar disorder (BD) is one of the most heritable mental illnesses, but the elucidation of its
genetic basis has proven to be a very challenging endeavor. Genome-Wide Association …

Drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis

N Hama, R Abe, A Gibson, EJ Phillips - The Journal of Allergy and Clinical …, 2022 - Elsevier
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic
symptoms (DIHS/DRESS) is one example of a severe delayed T-cell–mediated adverse …

Comorbidities of epilepsy: current concepts and future perspectives

MR Keezer, SM Sisodiya, JW Sander - The Lancet Neurology, 2016 - thelancet.com
The burden of comorbidity in people with epilepsy is high. Several diseases, including
depression, anxiety, dementia, migraine, heart disease, peptic ulcers, and arthritis are up to …

Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs

AD Broyles, A Banerji, S Barmettler, CM Biggs… - The Journal of Allergy …, 2020 - Elsevier
Allergists and clinical immunologists around the world are increasingly faced with the task of
addressing drug allergy and hypersensitivity due to the increase in drug reactions …

Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019

T Shiohara, Y Mizukawa - Allergology international, 2019 - jstage.jst.go.jp
abstract The aim of this review was to provide an updated overview of drug-induced
hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms …

Severe cutaneous adverse reactions to drugs

TA Duong, L Valeyrie-Allanore, P Wolkenstein… - The Lancet, 2017 - thelancet.com
During the past decade, major advances have been made in the accurate diagnosis of
severe cutaneous adverse reactions (SCARs) to drugs, management of their manifestations …

International Con sensus on drug allergy

P Demoly, NF Adkinson, K Brockow, M Castells… - Allergy, 2014 - Wiley Online Library
When drug reactions resembling allergy occur, they are called drug hypersensitivity
reactions (DHR s) before showing the evidence of either drug‐specific antibodies or T cells …

[HTML][HTML] The consequences of refractory epilepsy and its treatment

KD Laxer, E Trinka, LJ Hirsch, F Cendes, J Langfitt… - Epilepsy & behavior, 2014 - Elsevier
Abstract Seizures in some 30% to 40% of patients with epilepsy fail to respond to
antiepileptic drugs or other treatments. While much has been made of the risks of new drug …

Incidence and risk factors of drug‐induced liver injury

X Li, J Tang, Y Mao - Liver International, 2022 - Wiley Online Library
The epidemiology and aetiology of drug‐induced liver injury (DILI) vary across different
countries and populations. Overall, DILI is rare in the general population but has become …